Johnston Lori A 4
4 · AMGEN INC · Filed May 4, 2021
Insider Transaction Report
Form 4
AMGEN INCAMGN
Johnston Lori A
SVP, HR
Transactions
- Tax Payment
Common Stock
2021-05-01$239.64/sh−355$85,072→ 37,700 total - Tax Payment
Common Stock
2021-05-03$239.64/sh−335$80,279→ 37,365 total - Award
Nqso (Right to Buy)
2021-04-30+28,623→ 28,623 totalExercise: $239.64From: 2023-04-30Exp: 2031-04-30→ Common Stock (28,623 underlying) - Award
Common Stock
2021-04-30+3,296→ 38,055 total
Footnotes (4)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.
- [F2]These shares include the following RSUs granted under the Company's equity plans: 690 RSUs which will vest on 4/27/2022; 1,361 RSUs which will vest in installments of 670 on 5/3/2022 and 691 on 5/3/2023; 7,799 RSUs which will vest in installments of 2,573 on 11/1/2021, 2,574 on 11/1/2022 and 2,652 on 11/1/2023; 2,961 RSUs which vest in two installments of 977 on 5/5/2022 and 5/5/2023, and one installment of 1,007 on 5/5/2024; and 3,296 RSUs which vest in installments of 1,087 on 4/30/2023, 1,088 on 04/30/2024 and 1,121 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 564 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.